Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies-Reference-Cited by-同舟云学术

Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies

Published:2019-12-03 Issue:2 Volume:27 Page:108-116
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Kikuchi Eiji¹,Hayakawa Nozomi²,Fukumoto Keishiro²,Shigeta Keisuke²,Matsumoto Kazuhiro²

Affiliation:

1. Department of Urology St. Marianna University School of Medicine Kanagawa Japan

2. Department of Urology Keio University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14153

Reference83 articles.

1. BabjukM BurgerM CompératEet al.EAU guidelines on non-muscle-invasive baldder cancer (TaT1 and CIS).https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/

2. Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and Toxicity

3. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

4. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials

5. The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients’ access to novel therapeutics;Urologic Oncology: Seminars and Original Investigations;2023-09

2. Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG‐treated disease;International Journal of Urology;2023-07-31

3. Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer;Cancer Immunology, Immunotherapy;2023-03-16

4. Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis;Frontiers in Oncology;2022-11-17

5. Cytokeratin 5/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette–Guérin instillation;Pathology;2022-10